Search This Blog

Monday, April 20, 2026

Nektar positive 52-week Phase 2b topline results for alopecia areata

 

Nektar reports positive 52-week Phase 2b REZOLVE-AA topline results for rezpegaldesleukin in severe-to-very-severe alopecia areata

  • 52-week topline data come from Phase 2b REZOLVE-AA extension study and support advancement of rezpegaldesleukin into late-stage development.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)